Innoviva, Inc. (INVA)
NASDAQ·Healthcare·Biotechnology
$18.78
-1.68%
Mkt Cap $1.52B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (10 analysts)
$38.00
Range $34.00 – $42.00
Implied Upside
+102.4%
Consensus $38.00 vs current $18.78
NASDAQ·Healthcare·Biotechnology
$18.78
-1.68%
Mkt Cap $1.52B
Buy
5
Hold
0
Sell
0
Price Target (10 analysts)
$38.00
Range $34.00 – $42.00
+102.4%
Consensus $38.00 vs current $18.78